A formulation for pain relief and a method thereof

Abstract

A formulation for pain relief is disclosed. The formulation (100) includes a blend of one or more oils to relieve pain of a user, wherein the one or more oils includes 75 percent by weight of Tulsi oil (110), 5 percent by weight of mint oil (120), 10 percent by weight of lavender oil (130) and 10 percent by weight of jojoba oil (140).

Description

[0001] A FORMULATION FOR PAIN RELIEF AND A METHOD THEREOF EARLIEST PRIORITY DATE

[0002] This Application claims priority from a Complete patent application filed in India having Patent Application No. 202541002556, filed on January 10, 2025, and titled “A FORMULATION FOR PAIN RELIEF AND A METHOD THEREOF”

[0003] FIELD OF INVENTION

[0004] Embodiments of the present disclosure relate to the field of formulation, and more particularly, a formulation for pain relief and a method thereof.

[0005] BACKGROUND

[0006] Many people experience joint discomforts irrespective of age which may impact on daily activities. These joint discomforts often make even simple movements, such as bending, walking, feel challenging and uncomfortable. For example, if discomfort is linked to conditions like Restless Legs Syndrome (RLS), it becomes severe.

[0007] The Restless Legs Syndrome (RLS) affects people worldwide, causing an urge to move legs and discomfort. There is no proven treatment for the RLS, yet consequences of existing therapies take time to reduce pain and later involves negative effects on an affected area. Further, palliative treatments like warm baths, quick relief sprays and massages provide only temporary relief. Currently, there are several essential oils claimed to help relieve symptoms of the RLS. However, these several essential oils have limitations, including limited scientific evidence, potential skin irritation or allergic reactions on the affected area, and inability to offer long-term relief or address underlying causes.Hence, there is a need for an improved oil for pain reduction which addresses the aforementioned issue(s).

[0008] OBJECTIVE OF THE INVENTION

[0009] An objective of the invention is to formulate an oil with 75 percent of Tulsi oil, 5 percent of mint oil, 10 percent of lavender oil, and 10 percent of jojoba oil.

[0010] Another objective of the present invention is to apply a formulated oil to an affected area of a user body to provide a quick relief of pain.

[0011] BRIEF DESCRIPTION

[0012] In accordance with an embodiment of the present disclosure, a formulation for pain relief is provided. The formulation includes a blend of one or more oils to relieve pain of a user, wherein the one or more oils includes 75 percent by weight of Tulsi oil, 5 percent by weight of mint oil, 10 percent by weight of lavender oil, and 10 percent by weight of jojoba oil.

[0013] In accordance with another embodiment of the present disclosure, a method for relieving pain is provided. The method includes mixing, by a blender, one or more oils to relieve pain of a user, wherein the one or more oils includes 75 percent by weight of Tulsi oil, 5 percent by weight of mint oil, 10 percent by weight of lavender oil, 10 percent by weight of jojoba oil. The method also includes applying a blended oil to an affected area of the user for a predetermined time to relieve from the pain.

[0014] To further clarify the advantages and features of the present disclosure, a more particular description of the disclosure will follow by reference to specific embodiments thereof, which are illustrated in the appended figures. It is to be appreciated that these figures depict only typical embodiments of the disclosure and are therefore not to be considered limiting in scope. The disclosure will be described and explained with additional specificity and detail with the appended figures.BRIEF DESCRIPTION OF THE DRAWINGS

[0015] The disclosure will be described and explained with additional specificity and detail with the accompanying figures in which:

[0016] FIG. 1 is a block diagram representation of a formulation for pain relief in accordance with an embodiment of the present disclosure; and

[0017] FIG. 2 illustrates a flow chart representing the steps involved in a method for relieving pain in accordance with an embodiment of the present disclosure.

[0018] Further, those skilled in the art will appreciate that elements in the figures are illustrated for simplicity and may not have necessarily been drawn to scale. Furthermore, in terms of the construction of the device, one or more components of the device may have been represented in the figures by conventional symbols, and the figures may show only those specific details that are pertinent to understanding the embodiments of the present disclosure so as not to obscure the figures with details that will be readily apparent to those skilled in the art having the benefit of the description herein.

[0019] DETAILED DESCRIPTION

[0020] For the purpose of promoting an understanding of the principles of the disclosure, reference will now be made to the embodiment illustrated in the figures and specific language will be used to describe them. It will nevertheless be understood that no limitation of the scope of the disclosure is thereby intended. Such alterations and further modifications in the illustrated system, and such further applications of the principles of the disclosure as would normally occur to those skilled in the art are to be construed as being within the scope of the present disclosure.

[0021] The terms “comprises”, “comprising”, or any other variations thereof, are intended to cover a non-exclusive inclusion, such that a process or method that comprises a list ofsteps does not include only those steps but may include other steps not expressly listed or inherent to such a process or method. Similarly, one or more devices or subsystems or elements or structures or components preceded by "comprises... a" does not, without more constraints, preclude the existence of other devices, sub-systems, elements, structures, components, additional devices, additional sub-systems, additional elements, additional structures or additional components. Appearances of the phrase "in an embodiment", "in another embodiment" and similar language throughout this specification may, but not necessarily do, all refer to the same embodiment.

[0022] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which this disclosure belongs. The system, methods, and examples provided herein are only illustrative and not intended to be limiting.

[0023] In the following specification and the claims, reference will be made to a number of terms, which shall be defined to have the following meanings. The singular forms “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise.

[0024] Embodiments of the present disclosure relate to a formulation for pain relief. The formulation includes a blend of one or more oils to relieve pain of a user, wherein the one or more oils includes 75 percent by weight of Tulsi oil, 5 percent by weight of mint oil, 10 percent by weight of lavender oil, and 10 percent by weight of jojoba oil.

[0025] FIG. 1 is a block diagram representation of a formulation for pain relief in accordance with an embodiment of the present disclosure. The formulation (100) includes a blend of one or more oils to relieve pain of a user. In a specific embodiment, the formulation (100) is adapted to reduce pain and alleviate symptoms of Restless Legs Syndrome in the user. The Restless Legs Syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move legs, which is frequently accompanied by uncomfortable sensations. The uncomfortable sensations often occur when the user isat rest, particularly in evening or at night, and can significantly disrupt sleep, that causes fatigue and affects daily functioning. The RLS involves imbalances in dopamine, a neurotransmitter that controls muscle movement, as well as possible genetic and environmental factors. Further, the formulation (100) is adapted to activate neurotransmitters when applied by the user on the affected area, wherein the neurotransmitters include dopamine and serotonin.

[0026] The one or more oils anti-inflammatory and numbing properties are adapted to calm irritated nerves, reduces discomfort and itching on the affected area of the user.

[0027] The one or more oils includes 75 percent by weight of Tulsi oil (110). Typically, the Tulsi oil (110) is known for its adaptogenic properties that helps to regulate stress and anxiety, common triggers for RLS. The Tulsi oil (100) also has anti-inflammatory and muscle-relaxing properties.

[0028] Further, the one or more oils includes 5 percent by weight of mint oil (120). Typically, the mint's oil cooling sensation helps to numb skin, thereby reducing discomfort and itching associated with the RLS. Menthol content in the mints oil also relaxes muscles and improves circulation.

[0029] The one or more oil includes 10 percent by weight of lavender oil (130). Typically, the lavender's oil calming and sedative effects promote relaxation to reduce stress and anxiety that exacerbate the RLS. The lavender oil (130) has anti-inflammatory properties and can help soothe muscle cramps.

[0030] The mint oils’ menthol content and Lavender oil’s anti-inflammatory properties are adapted to enhance blood flow in the affected area.

[0031] The Tulsi oil (110), the mint oil (120) and the lavender oil (130) are adapted to relax muscles, reduce cramps and spasmsFurthermore, the one or more oils includes 10 percent by weight of jojoba oil (140). Typically, the jojoba oil is anti-inflammatory, and antioxidant rich.

[0032] In an example, consider a scenario, where the user ‘X’ formulates a blend of the one or more oils including 75 percent of Tulsi oil (110), 5 percent of mint oil, (120), 10 percent of lavender oil (130), and 10 percent of jojoba oil (140). Upon blending the one or more oils, the user X applies a blended oil to an affected area of the user X for a predetermined time to relieve the pain and symptoms of restless leg syndrome.

[0033] FIG. 2 illustrates a flow chart representing the steps involved in a method for relieving pain in accordance with an embodiment of the present disclosure. The method (200) includes mixing, by a blender, one or more oils to relieve pain of a user, wherein the one or more oils includes 75 percent by weight of Tulsi oil, 5 percent by weight of mint oil, 10 percent by weight of lavender oil, 10 percent by weight of jojoba oil in step 210. Combination of the Tulsi oil, the mint oil, and the lavender helps relax muscles, reducing cramping and spasms.

[0034] In one embodiment, the Tulsi oil, the mint oil and the lavender oil are adapted to relax muscles, reduce cramps and spasms.

[0035] In another embodiment, the one or more oils anti-inflammatory and numbing properties is adapted to calm irritated nerves, reduces discomfort and itching on the affected area of the user.

[0036] Yet, in another embodiment, the mint oils’ menthol content and Lavender oil’s antiinflammatory properties is adapted to enhance blood flow in the affected area.

[0037] In one embodiment, the Tulsi oil and the lavender oil is adapted to provide adaptogenic and calming effects to manage stress and anxiety.The method (200) also includes applying a blended oil to an affected area of the user for a predetermined time to relieve from the pain in step 220. Typically, massaging the blended oil on the affected area focusing on calves and thighs. In one embodiment, the blended oil is applied for 30 minutes to 1 hour before bedtime or as needed during a day.

[0038] Various embodiments of the formulation for pain relief and a method thereof as described above provides several advantages, including instant pain relief when the blended oil is applied on the affected area from symptoms of restless leg syndrome, making an effective option for the immediate comfort to the user. Further, the Tulsi oil, the mint oil, the lavender oil and the jojoba oil is a natural remedy that offers a gentle and safe for the user thereby avoiding chemical combinations and other conventional medications.

[0039] It will be understood by those skilled in the art that the foregoing general description and the following detailed description are exemplary and explanatory of the disclosure and are not intended to be restrictive thereof.

[0040] While specific language has been used to describe the disclosure, any limitations arising on account of the same are not intended. As would be apparent to a person skilled in the art, various working modifications may be made to the method in order to implement the inventive concept as taught herein.

[0041] The figures and the foregoing description give examples of embodiments. Those skilled in the art will appreciate that one or more of the described elements may well be combined into a single functional element. Alternatively, certain elements may be split into multiple functional elements. Elements from one embodiment may be added to another embodiment. For example, the order of processes described herein may be changed and are not limited to the manner described herein. Moreover, the actions of any flow diagram need not be implemented in the order shown; nor do all of the actsneed to be necessarily performed. Also, those acts that are not dependent on other acts may be performed in parallel with the other acts. The scope of embodiments is by no means limited by these specific examples.

Claims

I CLAIM:

1. A formulation (100) for pain relief comprising:characterized in that,wherein, the said formulation (100) comprises a blend of one or more oils to relieve pain of a user, wherein the one or more oils comprises:75 percent by weight of Tulsi oil; (110)5 percent by weight of mint oil; (120)10 percent by weight of lavender oil; and (130)10 percent by weight of jojoba oil. (140)2. The formulation (100) as claimed in claim 1, wherein the Tulsi oil, the mint oil and the lavender oil are adapted to relax muscles, reduce cramps and spasms.

3. The formulation (100) as claimed in claim 1, wherein the one or more oils antiinflammatory and numbing properties is adapted to calm irritated nerves, reduces discomfort and itching on the affected area of the user.

4. The formulation (100) as claimed in claim 1, wherein the mint oils’ menthol content and Lavender oil’s anti-inflammatory properties is adapted to enhance blood flow in the affected area.

5. The formulation (100) as claimed in claim 1, wherein the formulation (100) is adapted to reduce pain and alleviate symptoms of Restless Legs Syndrome in the user.

6. The formulation (100) as claimed in claim 1, wherein the Tulsi oil and the lavender oil is adapted to provide adaptogenic and calming effects to manage stress and anxiety.

7. The formulation (100) as claimed in claim 1, wherein the formulation (100) is adapted to activate neurotransmitters when applied by the user on the affected area, wherein the neurotransmitters comprises dopamine and serotonin.

8. A method (200) for relieving pain comprising:characterized in that,mixing, by a blender, one or more oils to relieve pain of a user, wherein the one or more oils comprises:75 percent by weight of Tulsi oil;5 percent by weight of mint oil;10 percent by weight of lavender oil;10 percent by weight of jojoba oil; and (210)applying a blended oil to an affected area of the user for a predetermined time to relieve from the pain. (220)9. The method (200) as claimed in claim 8, wherein the blended oil is adapted to enhance blood flow and circulation thereby reducing tingling and numbness in the affected area.

10. The method (200) as claimed in claim 8, wherein the blended oil has analgesic, anti-inflammatory effect adapted to reduce pain and discomfort in the affected area.

Images